Biotest AG
XHAM:BIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biotest AG
XHAM:BIO
|
DE |
|
F
|
Francotyp Postalia Holding AG
XBER:FPH
|
DE |
|
O
|
Optical Cable Corp
F:OCC
|
US |
|
P
|
Protagonist Therapeutics Inc
XBER:PGF
|
US |
|
M
|
Microsoft Corp
BMV:MSFT
|
US |
|
Medpace Holdings Inc
NASDAQ:MEDP
|
US |
|
F
|
Factset Research Systems Inc
XMUN:FA1
|
US |
|
P
|
Pultegroup Inc
DUS:PU7
|
US |
|
Bluestone Resources Inc
F:IX9D
|
CA |
|
Pirelli & C SpA
OTC:PLLIF
|
IT |
|
B
|
Berdikari Pondasi Perkasa Tbk PT
IDX:BDKR
|
ID |
|
I
|
Innergex Renewable Energy Inc
OTC:INGXF
|
CA |
|
Nostra Terra Oil and Gas Company PLC
F:LMU1
|
UK |
|
United Parcel Service Inc
NYSE:UPS
|
US |
|
T
|
Terna Rete Elettrica Nazionale SpA
XMUN:UEI
|
IT |
|
A
|
AGC Inc
F:SHJ
|
JP |
|
Aures Technologies SA
PAR:AURS
|
FR |
Dividends
Dividend Yield
Biotest AG
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Biotest AG
BIO have decreased by 0%.
Payout Ratio
Biotest AG
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for BIO is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BIO Price
Biotest AG
| Average Annual Return | 4.97% |
| Standard Deviation of Annual Returns | 12.68% |
| Max Drawdown | -28% |
| Market Capitalization | 795.6m EUR |
| Shares Outstanding | 39 571 452 |
| Percentage of Shares Shorted |
N/A
|
BIO Return Decomposition
Main factors of price return
Stock Splits
BIO's latest stock split occurred on Jul 15, 2015
The company executed a 3-for-1 stock split, meaning that for every share held, investors received 3 new shares.
Before the split, BIO traded at 25.0167 per share. Afterward, the share price was about 25.6439.
The adjusted shares began trading on Jul 15, 2015. This was the only stock split in BIO's history.
